Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Interferons in dermatology. Present-day standard

¹Department of Dermatology, Medical Centre Minden, Germany.

Dermatologic Clinics

|May 20, 1998

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients.

Experimental dermatology·2024

Same author

Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: A multicentric study in 100 patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Adenoma Detection Rate on Colonoscopy: an Argument for Focused Screening?

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2022

Same author

[Calprotectin-a key for diagnosing chronic inflammatory bowel disease in inflammatory dermatoses? : Three case reports].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2021

Same author

Corrigendum: Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

Same author

Smart local orbitals for efficient calculations within density functional theory and beyond.

The Journal of chemical physics·2020

Recombinant interferon, particularly in combination therapies, offers powerful new treatment options for various dermatologic conditions, including cancers and infections. Further research will expand its therapeutic applications in dermatology.

Area of Science:

Dermatology
Oncology
Immunology

Background:

Cytokines, specifically interferons, have shown therapeutic potential since the 1980s.
Recombinant interferon is approved for specific dermatologic conditions like Kaposi's sarcoma and melanoma.

Purpose of the Study:

To review the current and potential future applications of interferons in dermatologic therapy.
To highlight the significance of combination therapies involving interferons.

Main Methods:

Review of clinical trials and established therapeutic uses of recombinant interferon.
Analysis of existing data on interferon efficacy in various dermatologic indications.

Main Results:

Recombinant interferon is licensed for HIV-associated Kaposi's sarcoma, cutaneous T-cell lymphoma, and adjuvant melanoma therapy.

Related Experiment Videos

Interferon is not currently licensed for septic granulomatosis but shows promise.

Conclusions:

Interferon, especially in combination with other agents, presents significant therapeutic possibilities in dermatology.
Expanded use of interferons in monotherapy and combination therapy is anticipated for oncologic, inflammatory, and infectious dermatoses.